BioLargo, Inc. (BLGO) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, BioLargo, Inc. (BLGO) es una empresa del sector Basic Materials valorada en 0. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 15 mar 2026BioLargo, Inc. (BLGO) Exposición a Materiales y Productos Básicos
BioLargo, Inc. develops and commercializes environmental technologies, including advanced water treatment and odor control solutions, positioning itself within the basic materials sector. With a focus on addressing environmental challenges like PFAS contamination, the company aims to provide innovative and sustainable solutions for various industries.
Tesis de Inversión
BioLargo presents a compelling investment case centered on its innovative environmental technologies and growing market demand for sustainable solutions. The company's focus on addressing critical environmental challenges, such as PFAS contamination, positions it to capitalize on increasing regulatory pressures and market opportunities. Key value drivers include the commercialization of its Advanced Oxidation system and AEC technology, as well as the expansion of its CupriDyne Clean product line. With a gross margin of 43.9%, BioLargo demonstrates potential for profitability as it scales its operations. However, investors should be aware of the company's negative profit margin of -151.7% and the risks associated with operating in the competitive chemicals industry.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.05 billion, reflecting its current valuation in the OTC market.
- Gross margin of 43.9%, indicating the profitability of its core products and services.
- Negative P/E ratio of -4.43, reflecting current losses but potential for future earnings growth.
- Focus on addressing PFAS contamination, a growing environmental concern with increasing regulatory attention.
- Portfolio of patented technologies, providing a competitive advantage in the environmental solutions market.
Competidores y Pares
Fortalezas
- Innovative and patented technologies.
- Focus on addressing critical environmental challenges.
- Experienced management team.
- Diverse product portfolio.
Debilidades
- Limited financial resources.
- Negative profit margin.
- Reliance on OTC market for trading.
- Small market capitalization.
Catalizadores
- Ongoing: Commercialization of the Aqueous Electrostatic Concentrator (AEC) for PFAS removal.
- Ongoing: Expansion of the CupriDyne Clean product line for industrial odor and VOC control.
- Upcoming: Potential strategic partnerships and collaborations to expand market reach.
- Upcoming: Expansion into international markets with growing demand for sustainable solutions.
Riesgos
- Potential: Competition from larger and more established companies in the environmental solutions market.
- Potential: Technological obsolescence and the need for continuous innovation.
- Ongoing: Negative profit margin and limited financial resources.
- Potential: Changes in environmental regulations that could impact the demand for BioLargo's products.
- Ongoing: Dependence on the OTC market for trading, which can result in lower liquidity and higher volatility.
Oportunidades de crecimiento
- Expansion of PFAS Treatment Solutions: The market for PFAS treatment is rapidly growing due to increasing regulatory pressure and public awareness. BioLargo's Aqueous Electrostatic Concentrator (AEC) technology offers a potential solution for removing PFAS from water sources, targeting a market estimated to reach billions of dollars in the coming years. Successful deployment and commercialization of the AEC could drive significant revenue growth for BioLargo.
- Commercialization of Advanced Oxidation System (AOS): BioLargo's AOS technology offers an alternative approach to water treatment by generating oxidative species to remove contaminants. As industries seek more efficient and environmentally friendly water treatment solutions, the AOS presents a growth opportunity for BioLargo. The company can target industries such as agriculture, manufacturing, and wastewater treatment, with potential for licensing and direct sales.
- Growth in Industrial Odor and VOC Control with CupriDyne Clean: BioLargo's CupriDyne Clean products address the growing need for odor and VOC control in various industrial settings. As companies face increasing regulations and consumer demand for cleaner air, the market for odor and VOC control solutions is expanding. BioLargo can leverage its CupriDyne Clean product line to target industries such as waste management, food processing, and manufacturing.
- Strategic Partnerships and Collaborations: BioLargo can pursue strategic partnerships and collaborations to expand its market reach and accelerate the commercialization of its technologies. Collaborating with larger companies or research institutions can provide access to new markets, funding, and expertise. These partnerships can also help BioLargo validate its technologies and build credibility in the industry.
- Expansion into International Markets: BioLargo can explore opportunities to expand its operations into international markets, where environmental regulations are becoming stricter and demand for sustainable solutions is growing. Targeting regions with significant water scarcity or pollution challenges can provide new avenues for growth. Adapting its technologies and products to meet local needs and regulations will be crucial for success.
Oportunidades
- Growing demand for sustainable environmental solutions.
- Increasing regulatory pressure on PFAS contamination.
- Potential for strategic partnerships and collaborations.
- Expansion into international markets.
Amenazas
- Competition from larger and more established companies.
- Technological obsolescence.
- Changes in environmental regulations.
- Economic downturns.
Ventajas competitivas
- Patented technologies provide a competitive advantage.
- Proprietary formulations and processes create barriers to entry.
- Established relationships with key customers and partners.
- Expertise in environmental engineering and technology development.
Acerca de BLGO
BioLargo, Inc., founded in 1991 and based in Westminster, California, is an environmental technology innovator focused on solving complex environmental challenges. The company invents, develops, and commercializes a range of platform technologies aimed at addressing issues such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. BioLargo holds numerous patents and maintains a pipeline of products designed to offer sustainable and effective solutions. Its core offerings include the Advanced Oxidation system, a water treatment device; the Aqueous Electrostatic Concentrator (AEC) for PFAS removal; CupriDyne Clean industrial products for odor and VOC control; and advanced wound care products. The company also provides full-service environmental engineering services, leveraging its technologies and expertise to deliver comprehensive solutions to its clients.
Qué hacen
- Develops and commercializes environmental technologies.
- Offers solutions for PFAS contamination.
- Provides advanced water and wastewater treatment technologies.
- Offers industrial odor and VOC control solutions.
- Provides air quality control technologies.
- Develops infection control products.
- Provides full-service environmental engineering services.
Modelo de Negocio
- Sells and licenses its proprietary technologies.
- Provides environmental engineering services.
- Generates revenue through product sales, licensing agreements, and service contracts.
Contexto de la Industria
BioLargo operates within the basic materials sector, specifically in the chemicals industry, which is undergoing significant transformation due to increasing environmental regulations and growing demand for sustainable solutions. The market for water treatment technologies is expanding, driven by concerns over water scarcity and pollution. BioLargo's focus on PFAS removal and advanced oxidation positions it to compete with companies like AUXXF (Auxilio, Inc.), BIOF (Biofiltrations Environmental Inc.), DNCVF (Denison Mines Corp), FGPHF (Fluence Corporation Ltd), and ISVLF (InnoSepra Holdings Inc), offering differentiated solutions in niche markets.
Clientes Clave
- Municipalities and government agencies seeking water treatment solutions.
- Industrial facilities requiring odor and VOC control.
- Healthcare providers seeking infection control products.
- Commercial businesses needing environmental engineering services.
Finanzas
Gráfico e información
Precio de la acción de BioLargo, Inc. (BLGO): Price data unavailable
Últimas noticias
-
BioLargo Inc (BLGO) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges
Yahoo! Finance: BLGO News · 5 mar 2026
-
BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
seekingalpha.com · 5 mar 2026
-
BioLargo Reports Annual 2025 Operating and Financial Results
Yahoo! Finance: BLGO News · 5 mar 2026
-
BioLargo Reports Annual 2025 Operating and Financial Results
accessnewswire.com · 5 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para BLGO.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para BLGO.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de BLGO en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Últimas Noticias
BioLargo Inc (BLGO) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges
BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
BioLargo Reports Annual 2025 Operating and Financial Results
BioLargo Reports Annual 2025 Operating and Financial Results
Liderazgo: Dennis Calvert
CEO
Dennis Calvert serves as the CEO of BioLargo, Inc., managing a team of 40 employees. His background includes extensive experience in environmental technology and business development. He has been instrumental in guiding BioLargo's strategic direction and driving the commercialization of its innovative technologies. Calvert's leadership focuses on addressing critical environmental challenges and creating sustainable solutions for various industries.
Historial: Under Dennis Calvert's leadership, BioLargo has secured numerous patents and expanded its product portfolio to include advanced water treatment, odor control, and infection control solutions. He has overseen the development and commercialization of key technologies, such as the Advanced Oxidation system and the Aqueous Electrostatic Concentrator (AEC). Calvert has also focused on building strategic partnerships and collaborations to accelerate the company's growth.
Información del mercado OTC de BLGO
The OTC Other tier represents the lowest tier of the OTC market, where companies may have limited or no financial reporting requirements. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies often have less stringent listing standards, resulting in higher risk and lower transparency. This tier typically includes companies that are thinly traded, distressed, or have been delisted from major exchanges.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial reporting requirements increase the risk of information asymmetry.
- Lower trading volume and wider bid-ask spreads can lead to price volatility.
- Higher risk of fraud or manipulation due to less stringent regulatory oversight.
- Potential for delisting or trading suspension due to non-compliance with OTC regulations.
- Limited access to capital and financing options compared to companies on major exchanges.
- Verify the company's financial statements and SEC filings, if available.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's intellectual property and patents.
- Review the company's legal and regulatory compliance.
- Monitor news and press releases for any red flags or significant developments.
- Consult with a qualified financial advisor before investing.
- Patented technologies and innovative solutions.
- Focus on addressing critical environmental challenges.
- Experienced management team.
- Established relationships with key customers and partners.
Preguntas Comunes Sobre BLGO
¿Cuáles son los factores clave para evaluar BLGO?
BioLargo, Inc. (BLGO) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Innovative and patented technologies.. Riesgo principal a monitorear: Potential: Competition from larger and more established companies in the environmental solutions market.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de BLGO?
BLGO actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de BLGO?
Los precios de BLGO se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre BLGO?
La cobertura de analistas para BLGO incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en BLGO?
Las categorías de riesgo para BLGO incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Competition from larger and more established companies in the environmental solutions market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de BLGO?
La relación P/E para BLGO compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está BLGO sobrevalorada o infravalorada?
Determinar si BioLargo, Inc. (BLGO) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de BLGO?
BioLargo, Inc. (BLGO) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- OTC market data may be less reliable than major exchange data.
- Financial information may be limited due to disclosure requirements.